Vascular endothelial growth factor (VEGF) and its related receptor subtypes (VEGFR1, VEGFR2, and VEGFR3) are the major drivers of angiogenesis in NSCLC [9]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.